FTC Probes Illumina's $8B Deal For Cancer Detection Biz
The Federal Trade Commission has told Illumina that it wants to look more deeply into the biotech giant's planned $8 billion acquisition of Grail Inc., Illumina said....To view the full article, register now.
Already a subscriber? Click here to view full article